- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01622023
Timing of Intrauterine Insemination (IUI) 24 or 48 Hours After Spontaneous Luteinizing Hormone (LH) Peak
April 17, 2019 updated by: Blockeel Christophe, Universitair Ziekenhuis Brussel
Timing of IUI 24 or 48 Hours After Spontaneous LH Peak: a Randomised Controlled Trial
The aim of the present study is to prospectively evaluate whether performing an intra-uterine insemination 24 hours after the spontaneous LH peak may result in significantly higher ongoing pregnancy rates compared to 48 hours.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
435
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brussel, Belgium, 1090
- Christophe Blockeel
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 39 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- below 39 years of age on the day of LH peak
- donor semen
- natural cycle (without CC)
- cycle with less than 3 follicles reaching 15 mm of diameter or more.
- with basal hormonal values of progesterone ( < 1,2 ng/dl)
Exclusion Criteria:
The patients excluded are women
- who underwent more than 6 intrauterine inseminations,
- with tubal infertility
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Study group
intrauterine insemination after 24 hours
|
Artificial insemination is the process by which sperm is placed into the reproductive tract of a female for the purpose of impregnating the female by using means other than sexual intercourse or natural insemination.
Other Names:
|
ACTIVE_COMPARATOR: Control group
intrauterine insemination after 48 hours
|
Artificial insemination is the process by which sperm is placed into the reproductive tract of a female for the purpose of impregnating the female by using means other than sexual intercourse or natural insemination.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
pregnancy rate
Time Frame: end of 2013 (up to 2 years)
|
end of 2013 (up to 2 years)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
live birth rate
Time Frame: end of 2013 (up to 2 years)
|
end of 2013 (up to 2 years)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (ACTUAL)
June 1, 2013
Study Completion (ACTUAL)
June 1, 2013
Study Registration Dates
First Submitted
March 27, 2012
First Submitted That Met QC Criteria
June 15, 2012
First Posted (ESTIMATE)
June 18, 2012
Study Record Updates
Last Update Posted (ACTUAL)
April 19, 2019
Last Update Submitted That Met QC Criteria
April 17, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1/2012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Hopital Antoine BeclereUnknown
Clinical Trials on intra-uterine insemination
-
University Hospital, ToulouseTerminated
-
Sheba Medical CenterRabin Medical Center; Meir Medical Center; Shaare Zedek Medical CenterRecruitingOvarian Cancer | Fallopian Tube Cancer | Ovarian Carcinoma | Serous Cystadenocarcinoma | Primary Peritoneal CarcinomaIsrael
-
Ain Shams UniversityCompleted
-
University Health Network, TorontoPrincess Margaret Hospital, CanadaCompleted
-
Maisonneuve-Rosemont HospitalCompleted
-
Royan InstituteCompletedInfertilityIran, Islamic Republic of
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedPregnant Women With Foetuses Presenting With Intra-uterine Growth RestrictionFrance
-
Royan InstituteCompletedRecurrent Implantation FailureIran, Islamic Republic of
-
University Hospital, GhentCompletedAdhesion; Uterus, InternalBelgium
-
University Hospital, RouenTerminatedSpontaneous Intra Uterine Fetal DeathFrance